Omnicef 125/5Ml 40 Ml

Omnicef 12/40 Mg 5 ml

Description:

Omnicef 12/40 mg 5 ml (Omnicef 125 mg/5 ml suspension 40 ml) is an oral prescription antibiotic medicine containing cefdinir, a third-generation cephalosporin. It is used to treat a wide range of bacterial infections of the respiratory tract, ear, skin and soft tissues. Omnicef works by inhibiting bacterial cell wall synthesis, leading to the death of susceptible bacteria. This product is intended for systemic anti-infective therapy under medical supervision and is suitable for adults and children as directed by a physician.

Indications:

• Treatment of community-acquired pneumonia caused by susceptible bacteria.
• Treatment of acute bronchitis and acute exacerbations of chronic bronchitis.
• Treatment of pharyngitis and tonsillitis caused by susceptible organisms.
• Treatment of acute otitis media (middle ear infection), particularly in children.
• Treatment of acute sinusitis.
• Treatment of uncomplicated skin and soft tissue infections (such as cellulitis, impetigo, and wound infections) caused by susceptible bacteria.
• Used when a broad-spectrum oral cephalosporin antibiotic is indicated, as prescribed by a healthcare professional.

Active Ingredients / Key Components:

• Cefdinir – 125 mg per 5 ml oral suspension (equivalent strength based on product reference: OMNICEF 125mg/5ml susp. 40ml).
• Excipients: The full list of inactive ingredients (suspension base, sweeteners, stabilizers, flavoring agents, preservatives) is not available in the provided information. Please refer to the official package insert for the complete excipient list.

Dosage & Administration / How to Use:

• Use Omnicef only as prescribed by a physician. Dosage depends on the type and severity of infection, patient age, body weight, and kidney function.
• Adults and adolescents: Typical total daily dose of cefdinir is 300–600 mg per day, given once daily or divided every 12 hours, according to the doctor’s instructions. The exact volume in ml should be calculated by the prescriber based on 125 mg/5 ml strength.
• Children: The dose is usually calculated by body weight (mg/kg/day). The pediatrician will determine the appropriate dose and dosing frequency using the 125 mg/5 ml suspension. Do not adjust the dose without medical advice.
• Shake the bottle well before each use to ensure uniform suspension.
• Measure the dose accurately using the provided oral syringe or measuring cup; do not use household teaspoons.
• Omnicef may be taken with or without food. Taking it with food may help reduce potential stomach discomfort.
• Avoid giving Omnicef at the same time as iron supplements, iron-containing products, or antacids containing aluminum or magnesium, as they may reduce cefdinir absorption. If needed, separate doses by at least 2 hours (follow physician advice).
• Continue the full course of therapy exactly as prescribed, even if symptoms improve earlier, to prevent relapse and antibiotic resistance.
• If a dose is missed, give it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.

Clinical Benefits:

• Provides broad-spectrum antibacterial activity against many gram-positive and gram-negative organisms responsible for respiratory, ear, skin, and sinus infections.
• Helps rapidly relieve symptoms of bacterial infections such as fever, sore throat, cough, ear pain, sinus pressure, and skin redness or swelling when used appropriately.
• Oral suspension form is convenient for children and adults who have difficulty swallowing tablets or capsules.
• Third-generation cephalosporin with proven clinical efficacy and safety profile when used under medical supervision.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to cefdinir, other cephalosporins, or any component of the formulation.
• Use with extreme caution in patients with a history of severe hypersensitivity (anaphylaxis) to penicillins or other beta-lactam antibiotics due to possible cross-reactivity.
• Patients with renal impairment (reduced kidney function) may require dose adjustment; use only under strict medical supervision.
• Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, appropriate measures should be taken.
• Antibiotic-associated diarrhea and Clostridioides difficile–associated diarrhea (CDAD) have been reported with nearly all antibacterial agents, including cefdinir. Discontinue and seek medical advice if severe or persistent diarrhea occurs.
• Use in pregnancy and breastfeeding only if clearly needed and prescribed by a doctor. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
• Consult your doctor before use if you have kidney disease, history of gastrointestinal disease (especially colitis), or any significant chronic illness.
• Do not use this product without medical prescription or for viral infections such as common cold or influenza.
• Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: Diarrhea, loose stools, nausea, vomiting, abdominal pain, headache, rash, or mild skin reactions. These are usually transient and mild to moderate.
• Less common/serious side effects: Severe allergic reactions (swelling of face, lips, tongue, difficulty breathing, severe rash), severe or persistent diarrhea, blood in stools, marked fatigue, or unusual bruising. These require immediate medical attention.
• If any side effects are severe, persistent, or you notice any unusual symptoms, stop the medication and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Specific storage conditions after reconstitution (such as refrigeration and maximum number of days after mixing) are not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); please follow the instructions on the package and your pharmacist’s guidance.

Specifications:

• Product type: Oral antibiotic medicine (systemic anti-infective).
• Strength: cefdinir 125 mg per 5 ml oral suspension (based on OMNICEF 125mg/5ml reference).
• Form: Oral suspension.
• Pack size: 40 ml bottle (as per OMNICEF 125mg/5ml susp. 40ml reference).
• Intended users: Adults and children as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.